Geisler, Tobias <br/><br/>
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.  [electronic resource] 

 -  International journal of stroke : official journal of the International Stroke Society  12 2017 
 - 985-990 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1747-4949 
<br/><br/><label>Standard No.: </label>10.1177/1747493016681019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aspirin--therapeutic use<br/>Brain--diagnostic imaging<br/>Embolism--diagnostic imaging<br/>Factor Xa Inhibitors--therapeutic use<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>Pyrazoles--therapeutic use<br/>Pyridones--therapeutic use<br/>Research Design<br/>Secondary Prevention<br/>Stroke--diagnostic imaging